Sign in Subscribe
Nanoparticles

Nanoparticles Show Promise in Targeting Inflammation and Disease

Strategic Insights

— 1 min read

Researchers at Hannover Medical School in Germany have made a significant discovery in the field of nanotechnology. The study, published in PLOS One, involved the use of magnetic nanoporous silica nanoparticles (MNPSNP) functionalized with either Polyethylenglycol (PEG) or CD-47 to target inflammation and disease. The research found that the nanoparticles accumulated mainly in the liver and spleen, with higher accumulation rates in areas with more severe signs of inflammation.

The study's lead author, Janin Reifenrath, noted that the nanoparticles were detectable on both implant materials, but the accumulation rate was very low. Despite this, the research suggested that inflammatory cells might be essential for the delivery of nanoparticles into inflamed regions.

Key Takeaways:

  • The study used magnetic nanoporous silica nanoparticles (MNPSNP) functionalized with either Polyethylenglycol (PEG) or CD-47 to target inflammation and disease.
  • The nanoparticles accumulated mainly in the liver and spleen, with higher accumulation rates in areas with more severe signs of inflammation.
  • The study found that inflammatory cells might be essential for the delivery of nanoparticles into inflamed regions.
  • The research was conducted in an in vivo mouse model of implant infection.
  • The study's lead author, Janin Reifenrath, noted that the nanoparticles were detectable on both implant materials, but the accumulation rate was very low.
  • Financial support for the research came from Deutsche Forschungsgemeinschaft.
  • The study concluded that the nanoparticles showed promise in targeting inflammation and disease, but further research is needed to fully understand their potential.
  • The study was published in PLOS One on June 13, 2025.
  • The research was conducted in an in vivo mouse model of implant infection, with 32 mice included in the study.
  • The nanoparticles were successfully functionalized with PEG or CD-47.
  • Nanoparticle accumulation rates were analyzed in dependence on the functionalization.
  • Higher accumulation rates in areas with more severe signs of inflammation indicate that inflammatory cells might be essential for the delivery of nanoparticles into inflamed regions.

Sources:

  • NewsRx. Study Findings from Hannover Medical School Provide New Insights into Nanoparticles (Comparison of Accumulation and Distribution of Pegylated and Cd-47-functionalized Magnetic Nanoporous Silica Nanoparticles In an in Vivo ...). Health & Medicine Week. June 13, 2025; p 7269.
  • Comparison of Accumulation and Distribution of Pegylated and Cd-47-functionalized Magnetic Nanoporous Silica Nanoparticles In an in Vivo Mouse Model of Implant Infection. PLOS One, 2025;20(5).

Read more